A role for cannabinoids in the treatment of myotonia? Report of compassionate use in a small cohort of patients
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A role for cannabinoids in the treatment of myotonia? Report of compassionate use in a small cohort of patients
Authors
Keywords
-
Journal
JOURNAL OF NEUROLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-10-26
DOI
10.1007/s00415-019-09593-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety, efficacy, and mechanisms of action of cannabinoids in neurological disorders
- (2019) Daniel Friedman et al. LANCET NEUROLOGY
- Medicinal use of cannabis based products and cannabinoids
- (2019) Tom P Freeman et al. BMJ-British Medical Journal
- Myotone Dystrophien, nicht dystrophe Myotonien und periodische Paralysen
- (2018) Christiane Schneider-Gold et al. AKTUELLE NEUROLOGIE
- The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews
- (2018) Suzanne Nielsen et al. Current Neurology and Neuroscience Reports
- Core Clinical Phenotypes in Myotonic Dystrophies
- (2018) Stephan Wenninger et al. Frontiers in Neurology
- Effects of non-euphoric plant cannabinoids on muscle quality and performance of dystrophic mdx mice
- (2018) Fabio Arturo Iannotti et al. BRITISH JOURNAL OF PHARMACOLOGY
- Dystrophische und nicht-dystrophische Myotonien
- (2018) Federica Montagnese et al. FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
- Effect of Mexiletine on Muscle Stiffness in Patients With Nondystrophic Myotonia Evaluated Using Aggregated N-of-1 Trials
- (2018) Bas C. Stunnenberg et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cannabis use in myotonic dystrophy patients in Germany and USA: a pilot survey
- (2018) Federica Montagnese et al. JOURNAL OF NEUROLOGY
- Open-label trial of ranolazine for the treatment of paramyotonia congenita
- (2018) Samantha Lorusso et al. MUSCLE & NERVE
- High frequency of gastrointestinal manifestations in myotonic dystrophy type 1 and type 2
- (2017) James E. Hilbert et al. NEUROLOGY
- Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol
- (2017) Douglas L Boggs et al. NEUROPSYCHOPHARMACOLOGY
- Cannabidiol: State of the art and new challenges for therapeutic applications
- (2017) Simona Pisanti et al. PHARMACOLOGY & THERAPEUTICS
- Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others?
- (2017) Mauro Maccarrone et al. Expert Review of Clinical Pharmacology
- Clinical/Therapeutic Approaches for Cannabinoid Ligands in Central and Peripheral Nervous System Diseases
- (2016) Katarzyna Fijał et al. CLINICAL NEUROPHARMACOLOGY
- Cannabinoid signalling inhibits sarcoplasmic Ca2+release and regulates excitation-contraction coupling in mammalian skeletal muscle
- (2016) Tamás Oláh et al. JOURNAL OF PHYSIOLOGY-LONDON
- A Molecular Signature of Myalgia in Myotonic Dystrophy 2
- (2016) Rabih Moshourab et al. EBioMedicine
- Cannabinoids for Medical Use
- (2015) Penny F. Whiting et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Patient-Reported Impact of Symptoms in Myotonic Dystrophy Type 2 (PRISM-2)
- (2015) Chad Heatwole et al. NEUROLOGY
- Endocannabinoid signaling at the periphery: 50 years after THC
- (2015) Mauro Maccarrone et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Involvement of central and peripheral cannabinoid receptors on antinociceptive effect of tetrahydrocannabinol in muscle pain
- (2014) Ana Bagüés et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Non-dystrophic myotonia: prospective study of objective and patient reported outcomes
- (2013) Jaya R. Trivedi et al. BRAIN
- Nondystrophic myotonia: Challenges and future directions
- (2013) Jaya R. Trivedi et al. EXPERIMENTAL NEUROLOGY
- Teaching Video NeuroImages: Trapezius myotonia percussion sign in myotonic dystrophy type 2
- (2013) N. E. Johnson et al. NEUROLOGY
- Mexiletine for Symptoms and Signs of Myotonia in Nondystrophic Myotonia
- (2012) Jeffrey M. Statland JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1)
- (2012) C. Heatwole et al. NEUROLOGY
- Pain in patients with myotonic dystrophy type 2: A postal survey in finland
- (2011) Kimmo I. Suokas et al. MUSCLE & NERVE
- The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment
- (2009) E. Matthews et al. BRAIN
- Cannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats
- (2008) Marnie Duncan et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Cannabinoid Receptors: Where They are and What They do
- (2008) K. Mackie JOURNAL OF NEUROENDOCRINOLOGY
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started